Combinations of IL-7 with temozolomide for the treatment of glioblastoma [64] and with atelizumab for the treatment of skin cancer [100], melanoma, and squamous cell carcinoma of the skin [101] are under ongoing investigation. Here, IL7 is linked to melanoma.